Form4insider filings, from the source

SEC Form 3 · accession 0001209191-18-002960

Strongbridge Biopharma plc · SBBP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Jan 1, 2018
Accepted (ET)
Jan 9, 2018 · 4:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001634432

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary Shares, $0.01 par valueF1,F2holding———4,141,308D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Ordinary Shares Warrant (right to buy)F1,F2$2.50holding———Jun 28, 2017Jun 28, 2022Ordinary Shares, $0.01 par value1,000,000—D

Explanation of responses